Market Access Views & Analysis

Views & Analysis

Coronavirus pharma news roundup – 24/07/20

With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie ahead.

Views & Analysis

MSD’s David Peacock on moving UK healthcare forward

David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations.

Views & Analysis

Coronavirus pharma news roundup - 17/07/20

Coronavirus vaccine trials continue – but experts warn that it’s too early to get hopes up. Meanwhile, the rise in digital health looks like it’s here to stay after the pandemic.

Views & Analysis

Rebooting the healthcare system post-COVID-19

Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake of COVID-19.

Views & Analysis

Coronavirus pharma news roundup - 10/07/20

As coronavirus vaccines and treatments advance rapidly through research and development, the world starts to consider what drugs and digital tools might be needed in the ‘new normal’.

Views & Analysis

Packaged Pills in aluminium blisters stacked on each other

How generic medicines increase patient access to treatment

The UK writes the most generic prescriptions across Europe and generics play a vital role in ensuring the sustainability of the country’s healthcare sector. I

Coronavirus pharma news roundup – 24/07/20

MSD’s David Peacock on moving UK healthcare forward

Coronavirus pharma news roundup - 17/07/20

Rebooting the healthcare system post-COVID-19

Coronavirus pharma news roundup - 10/07/20

How generic medicines increase patient access to treatment

Andexxa reaches the end of the line in the US

How to meet your physicians where they are online

Views & Analysis

Editor's Picks